Forian Inc. to Announce Third Quarter 2024 Results on November 13, 2024
Forian (Nasdaq: FORA), a provider of data science driven information and analytics solutions to healthcare and life sciences industries, has scheduled its third quarter 2024 financial results announcement for November 13, 2024, after market close. The company will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the results. A replay of the call will be available on the company's investor website following the conclusion.
Forian (Nasdaq: FORA), un fornitore di soluzioni di informazione e analisi basate sulla scienza dei dati per le industrie sanitarie e delle scienze della vita, ha programmato l' per il 13 novembre 2024, dopo la chiusura del mercato. L'azienda ospiterà una teleconferenza e una trasmissione in diretta alle 16:30 ET nello stesso giorno per discutere i risultati. Una registrazione della chiamata sarà disponibile sul sito web per gli investitori dell'azienda dopo la conclusione.
Forian (Nasdaq: FORA), un proveedor de soluciones de información y análisis impulsadas por ciencia de datos para las industrias de salud y ciencias de la vida, ha programado su anuncio de resultados financieros del tercer trimestre de 2024 para el 13 de noviembre de 2024, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica y transmisión web a las 4:30 p.m. ET el mismo día para discutir los resultados. Una repetición de la llamada estará disponible en el sitio web para inversores de la compañía tras su conclusión.
포리안 (Nasdaq: FORA)은 의료 및 생명 과학 산업을 위한 데이터 과학 기반 정보 및 분석 솔루션 제공업체로, 2024년 3분기 재무 결과 발표를 2024년 11월 13일 시장 종료 후에 예정하고 있습니다. 같은 날 오후 4시 30분 ET에 결과를 논의하기 위한 콘퍼런스 콜 및 웹 캐스트를 개최할 예정입니다. 통화 내용은 결론 후 회사의 투자자 웹사이트에서 다시 볼 수 있습니다.
Forian (Nasdaq: FORA), un fournisseur de solutions d'information et d'analyse axées sur la science des données pour les secteurs de la santé et des sciences de la vie, a prévu son annonce des résultats financiers du troisième trimestre 2024 pour le 13 novembre 2024, après la clôture du marché. L'entreprise organisera un appel de conférence et un webinaire le même jour à 16h30 ET pour discuter des résultats. Un enregistrement de l'appel sera disponible sur le site web des investisseurs de l'entreprise après la conclusion.
Forian (Nasdaq: FORA), ein Anbieter von datengestützten Informations- und Analyselösungen für die Gesundheits- und Lebenswissenschaftsbranchen, hat seine Ankündigung der finanziellen Ergebnisse des dritten Quartals 2024 für den 13. November 2024 nach Börsenschluss angesetzt. Das Unternehmen wird am gleichen Tag um 16:30 Uhr ET eine Telefonkonferenz und ein Webcast abhalten, um die Ergebnisse zu besprechen. Eine Wiederholung des Anrufs wird nach Abschluss auf der Investorenwebsite des Unternehmens verfügbar sein.
- None.
- None.
NEWTOWN, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its third quarter 2024 financial results on Wednesday, November 13, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on November 13, 2024 to discuss the results.
To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/rj92ayah. This information is also available on our website at www.forian.com/investors. The earnings release along with a replay of the call promptly following its conclusion will be available at the same site.
About Forian
Forian provides a unique suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance for customers within the traditional and emerging life sciences and healthcare payer and provider segments and, with its recent acquisition of Kyber Data Science, the financial services industry. Forian has industry leading expertise in acquiring, integrating, normalizing and commercializing large scale healthcare data assets. Forian’s information products overlay sophisticated data management and data science capabilities on top of a comprehensive clinical data lake to identify unique relationships, create distinctive information assets and generate proprietary insights. For more information, please visit the Company’s website at www.forian.com.
Cautionary Statements Regarding Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, which may include GAAP and non- GAAP financial measures, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions and variations or negatives of these words. Forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control and are not guarantees of future results, such as statements about future financial and operating results, company strategy and intended product offerings and market positioning. These and other forward- looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Factors that could cause actual results to differ include, but are not limited to, those risks and uncertainties associated with operations, strategy and goals, our ability to execute on our strategy and the additional risks and uncertainties set forth more fully under the caption “Risk Factors” in Forian’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the United States Securities and Exchange Commission (“SEC”) on March 29, 2024, and elsewhere in Forian’s filings and reports with the SEC. Forward-looking statements contained in this release are made as of the date hereof, and we undertake no duty to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.
Media and Investor Contact:
forian.com/investors
ir@forian.com
267-225-6263
SOURCE: Forian Inc.
FAQ
When will Forian (FORA) release Q3 2024 earnings?
What time is Forian's (FORA) Q3 2024 earnings call?